|
"高嘉宏"的相关文件
显示项目 11-20 / 491 (共50页)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目
| 臺大學術典藏 |
2018-09-10T15:24:59Z |
Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection.
|
Huei-Ru Cheng, Jia-Horng Kao, Hui-Lin Wu, Tai-Chung Tseng, Chen-Hua Liu, Hung-Chih Yang, Tung-Hung Su, Pei-Jer Chen, Ding-Shinn Chen, Chun-Jen Liu; Cheng, Huei-Ru;Kao, Jia-Horng;Wu, Hui-Lin;Tseng, Tai-Chung;Liu, Chen-Hua;Yang, Hung-Chih;Su, Tung-Hung;Chen, Pei-Jer;Chen, Ding-Shinn;Liu, Chun-Jen; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲; HUNG-CHIH YANG; Cheng, Huei-Ru; Kao, Jia-Horng; CHUN-JEN LIU; PEI-JER CHEN; Wu, Hui-Lin; CHEN-HUA LIU; Tseng, Tai-Chung; Liu, Chen-Hua; DING-SHINN CHEN; Yang, Hung-Chih; TUNG-HUNG SU; JIA-HORNG KAO; Su, Tung-Hung; Chen, Pei-Jer; Chen, Ding-Shinn; Liu, Chun-Jen |
| 臺大學術典藏 |
2018-09-10T15:24:58Z |
Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients.
|
Chia-Chi Wang, Chen-Hua Liu, Chih-Lin Lin, Pin-Chao Wang, Tai-Chung Tseng, Hans Hsienhong Lin, Jia-Horng Kao; Wang, Chia-Chi;Liu, Chen-Hua;Lin, Chih-Lin;Wang, Pin-Chao;Tseng, Tai-Chung;Lin, Hans Hsienhong;Kao, Jia-Horng; Wang, Chia-Chi;Liu, Chen-Hua;Lin, Chih-Lin;Wang, Pin-Chao;Tseng, Tai-Chung;Lin, Hans Hsienhong;Kao, Jia-Horng; 劉振驊;高嘉宏; 劉振驊;高嘉宏; Wang, Chia-Chi; Hsu, Wan-Tseng; CHEN-HUA LIU; Liu, Chen-Hua; Shen, Li-Jiuan; JIA-HORNG KAO; Liu, Chen-Hua; Lee, Chii-Ming; Lin, Chih-Lin; Lin, Chih-Lin; Wang, Pin-Chao; Wang, Pin-Chao; Tseng, Tai-Chung; Tseng, Tai-Chung; Lin, Hans Hsienhong; Lin, Hans Hsienhong; Kao, Jia-Horng; Kao, Jia-Horng; 李啟明; 沈麗娟 |
| 臺大學術典藏 |
2018-09-10T15:24:57Z |
Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naïve Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study.
|
Chen-Hua Liu, Wang-Hui Sheng, Hsin-Yun Sun, Szu-Min Hsieh, Yi-Chun Lo, Chun-Jen Liu, Tung-Hung Su, Hung-Chih Yang, Wen-Chun Liu, Pei-Jer Chen, Ding-Shinn Chen, Chien-Ching Hung, Jia-Horng Kao; Liu, Chen-Hua;Sheng, Wang-Hui;Sun, Hsin-Yun;Hsieh, Szu-Min;Lo, Yi-Chun;Liu, Chun-Jen;Su, Tung-Hung;Yang, Hung-Chih;Liu, Wen-Chun;Chen, Pei-Jer;Chen, Ding-Shinn;Hung, Chien-Ching;Kao, Jia-Horng; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;孫幸筠;劉俊人;謝思民;陳培哲;盛望徽;洪健清; Chang, Tien-Jyun; Liu, Chen-Hua; HUNG-CHIH YANG; Sheng, Wang-Hui; CHUN-JEN LIU; Tseng, Hsing-Chi; Sun, Hsin-Yun; Liu, Meng-Wei; SZU-MIN HSIEH; PEI-JER CHEN; Chang, Yi-Cheng; Hsieh, Szu-Min; Hsieh, Meng-Lun; Lo, Yi-Chun; CHEN-HUA LIU; Liu, Chun-Jen; Chuang, Lee-Ming; DING-SHINN CHEN; TUNG-HUNG SU; Su, Tung-Hung; Yang, Hung-Chih; HSIN-YUN SUN; Liu, Wen-Chun; JIA-HORNG KAO; CHIEN-CHING HUNG; Chen, Pei-Jer; Chen, Ding-Shinn; Hung, Chien-Ching; Kao, Jia-Horng; ?????; ?i?H??; ?i??g; ?????? |
| 臺大學術典藏 |
2018-09-10T15:22:34Z |
Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial
|
Liu, Chen-Hua;Huang, Chung-Feng;Liu, Chun-Jen;Dai, Chia-Yen;Huang, Jee-Fu;Lin, Jou-Wei;Liang, Cheng-Chao;Yang, Sheng-Shun;Lin, Chih-Lin;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Kao, Jia-Horng;Yu, Ming-Lung; Liu, Chen-Hua;Huang, Chung-Feng;Liu, Chun-Jen;Dai, Chia-Yen;Huang, Jee-Fu;Lin, Jou-Wei;Liang, Cheng-Chao;Yang, Sheng-Shun;Lin, Chih-Lin;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Kao, Jia-Horng;Yu, Ming-Lung; Liu, C.-H. and Huang, C.-F. and Liu, C.-J. and Dai, C.-Y. and Huang, J.-F. and Lin, J.-W. and Liang, C.-C. and Yang, S.-S. and Lin, C.-L. and Su, T.-H. and Yang, H.-C. and Chen, P.-J. and Chen, D.-S. and Chuang, W.-L. and Kao, J.-H. and Yu, M.-L.; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲;林昭維; Liu, Chen-Hua; HUNG-CHIH YANG; CHUN-JEN LIU; Huang, Chung-Feng; PEI-JER CHEN; Liu, Chun-Jen; Dai, Chia-Yen; CHEN-HUA LIU; DING-SHINN CHEN; Huang, Jee-Fu; Lin, Jou-Wei; TUNG-HUNG SU; JIA-HORNG KAO; Liang, Cheng-Chao; Yang, Sheng-Shun; Lin, Chih-Lin; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung |
| 臺大學術典藏 |
2018-09-10T15:18:59Z |
Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapy
|
陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲; Liang, Cheng-Chao; HUNG-CHIH YANG; Liu, Chen-Hua; CHUN-JEN LIU; Chung, Chen-Shuan; PEI-JER CHEN; CHEN-HUA LIU; Lin, Cheng-Kuan; Chen, Hsiao-Jan; Su, Tung-Hung; DING-SHINN CHEN; TUNG-HUNG SU; Yang, Hung-Chih; JIA-HORNG KAO; Liu, Chun-Jen; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; Liang, Cheng-Chao;Liu, Chen-Hua;Chung, Chen-Shuan;Lin, Cheng-Kuan;Su, Tung-Hung;Yang, Hung-Chih;Liu, Chun-Jen;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; Liang, C.-C. and Liu, C.-H. and Chung, C.-S. and Lin, C.-K. and Su, T.-H. and Yang, H.-C. and Liu, C.-J. and Chen, P.-J. and Chen, D.-S. and Kao, J.-H. |
| 臺大學術典藏 |
2018-09-10T15:18:58Z |
Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers
|
TUNG-HUNG SU; JIA-HORNG KAO; Kuo, Stephanie Fang-Tzu; Verbree, Femke Carolien; Su, Tung-Hung; Wang, Chia-Chi; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; Tseng, Tai-Chung;Liu, Chun-Jen;Yang, Hung-Chih;Chen, Chi-Ling;Yang, Wan-Ting;Tsai, Cheng-Shiue;Kuo, Stephanie Fang-Tzu;Verbree, Femke Carolien;Su, Tung-Hung;Wang, Chia-Chi;Liu, Chen-Hua;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; Tseng, T.-C. and Liu, C.-J. and Yang, H.-C. and Chen, C.-L. and Yang, W.-T. and Tsai, C.-S. and Kuo, S.F.-T. and Verbree, F.C. and Su, T.-H. and Wang, C.-C. and Liu, C.-H. and Chen, P.-J. and Chen, D.-S. and Kao, J.-H.; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲;陳祈玲; HUNG-CHIH YANG; Tseng, Tai-Chung; Liu, Chun-Jen; CHUN-JEN LIU; PEI-JER CHEN; Yang, Hung-Chih; CHEN-HUA LIU; Chen, Chi-Ling; Yang, Wan-Ting; DING-SHINN CHEN; Tsai, Cheng-Shiue |
| 臺大學術典藏 |
2018-09-10T15:18:57Z |
Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition
|
Su, T.-H. and Shiau, C.-W. and Jao, P. and Liu, C.-H. and Liu, C.-J. and Tai, W.-T. and Jeng, Y.-M. and Yang, H.-C. and Tseng, T.-C. and Huang, H.-P. and Cheng, H.-R. and Chen, P.-J. and Chen, K.-F. and Kao, J.-H. and Chen, D.-S.; Su, Tung-Hung;Shiau, Chung-Wai;Jao, Ping;Liu, Chen-Hua;Liu, Chun-Jen;Tai, Wei-Tien;Jeng, Yung-Ming;Yang, Hung-Chih;Tseng, Tai-Chung;Huang, Hsiang-Po;Cheng, Huei-Ru;Chen, Pei-Jer;Chen, Kuen-Feng;Kao, Jia-Horng;Chen, Ding-Shinn; Su, Tung-Hung;Shiau, Chung-Wai;Jao, Ping;Liu, Chen-Hua;Liu, Chun-Jen;Tai, Wei-Tien;Jeng, Yung-Ming;Yang, Hung-Chih;Tseng, Tai-Chung;Huang, Hsiang-Po;Cheng, Huei-Ru;Chen, Pei-Jer;Chen, Kuen-Feng;Kao, Jia-Horng;Chen, Ding-Shinn; 陳定信;劉振驊;高嘉宏;鄭永銘;楊宏志;蘇東弘;陳昆鋒;劉俊人;陳培哲; 陳定信;劉振驊;高嘉宏;鄭永銘;楊宏志;蘇東弘;陳昆鋒;劉俊人;陳培哲; HUNG-CHIH YANG; Su, Tung-Hung; HSIANG-PO HUANG; Shiau, Chung-Wai; Jao, Ping; CHUN-JEN LIU; Liu, Chen-Hua; PEI-JER CHEN; YUNG-MING JENG; Liu, Chun-Jen; CHEN-HUA LIU; Tai, Wei-Tien; DING-SHINN CHEN; Cheng, Wern-Cherng; Jeng, Yung-Ming; Yang, Hung-Chih; TUNG-HUNG SU; JIA-HORNG KAO; Tseng, Tai-Chung; Huang, Hsiang-Po; Cheng, Huei-Ru; Chen, Pei-Jer; Chen, Kuen-Feng; Kao, Jia-Horng; Chen, Ding-Shinn |
| 臺大學術典藏 |
2018-09-10T15:18:57Z |
Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: A randomized trial
|
Liu, Chen-Hua;Huang, Chung-Feng;Liu, Chun-Jen;Dai, Chia-Yen;Huang, Jee-Fu;Lin, Jou-Wei;Liang, Cheng-Chao;Yang, Sheng-Shun;Lin, Chih-Lin;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Kao, Jia-Horng;Yu, Ming-Lung; Liu, Chen-Hua;Huang, Chung-Feng;Liu, Chun-Jen;Dai, Chia-Yen;Huang, Jee-Fu;Lin, Jou-Wei;Liang, Cheng-Chao;Yang, Sheng-Shun;Lin, Chih-Lin;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Kao, Jia-Horng;Yu, Ming-Lung; Liu, C.-H. and Huang, C.-F. and Liu, C.-J. and Dai, C.-Y. and Huang, J.-F. and Lin, J.-W. and Liang, C.-C. and Yang, S.-S. and Lin, C.-L. and Su, T.-H. and Yang, H.-C. and Chen, P.-J. and Chen, D.-S. and Chuang, W.-L. and Kao, J.-H. and Yu, M.-L.; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲;林昭維; Wu, Cho-Kai; Liu, Chen-Hua; HUNG-CHIH YANG; CHUN-JEN LIU; Su, Mao-Yuan; Huang, Chung-Feng; PEI-JER CHEN; Lee, Jen-Kuang; Liu, Chun-Jen; Dai, Chia-Yen; Chiang, Fu-Tien; CHEN-HUA LIU; Hwang, Juey-Jen; Huang, Jee-Fu; DING-SHINN CHEN; Lin, Jiunn-Lee; TUNG-HUNG SU; Lin, Jou-Wei; JIA-HORNG KAO; Chen, Jin-Jer; Liang, Cheng-Chao; Yang, Sheng-Shun; Liu, Fu-Tong; Lin, Chih-Lin; Tsai, Chia-Ti; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung; ??????; ?L?T??; ?????; ??Z??; ?d????; ???礯; ?????? |
| 臺大學術典藏 |
2018-09-10T15:18:57Z |
Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial
|
DING-SHINN CHEN; Hung, Peir-Haur; Tsai, Hung-Bin; JIA-HORNG KAO; Lee, Chih-Yuan; Chen, Shih-I; Yang, Sheng-Shun; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Yu, Ming-Lung; Kao, Jia-Horng; TUNG-HUNG SU; Liu, Chen-Hua;Liu, Chun-Jen;Huang, Chung-Feng;Lin, Jou-Wei;Dai, Chia-Yen;Liang, Cheng-Chao;Huang, Jee-Fu;Hung, Peir-Haur;Tsai, Hung-Bin;Tsai, Meng-Kun;Lee, Chih-Yuan;Chen, Shih-I;Yang, Sheng-Shun;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Yu, Ming-Lung;Kao, Jia-Horng; Liu, C.-H. and Liu, C.-J. and Huang, C.-F. and Lin, J.-W. and Dai, C.-Y. and Liang, C.-C. and Huang, J.-F. and Hung, P.-H. and Tsai, H.-B. and Tsai, M.-K. and Lee, C.-Y. and Chen, S.-I. and Yang, S.-S. and Su, T.-H. and Yang, H.-C. and Chen, P.-J. and Chen, D.-S. and Chuang, W.-L. and Yu, M.-L. and Kao, J.-H.; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;李志元;劉俊人;陳世宜;陳培哲;蔡孟昆;林昭維;蔡宏斌; HUNG-CHIH YANG; Liu, Chen-Hua; Liu, Chun-Jen; MENG-KUN TSAI; Huang, Chung-Feng; CHUN-JEN LIU; PEI-JER CHEN; Lin, Jou-Wei; HUNG-BIN TSAI; Dai, Chia-Yen; Liang, Cheng-Chao; CHEN-HUA LIU; Huang, Jee-Fu |
| 臺大學術典藏 |
2018-09-10T15:18:40Z |
Circulating mRNA Profiling in Esophageal Squamous Cell Carcinoma Identifies FAM84B As A Biomarker in Predicting Pathological Response to Neoadjuvant Chemoradiation
|
陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 林昭維; Hsu, Feng-Ming; Liu, Chen-Hua; YIH-LEONG CHANG; Cheng, Jason Chia-Hsien; Huang, Chung-Feng; ERIC YAO-YU CHUANG; Chang, Yih-Leong; JANG-MING LEE; Liu, Chun-Jen; Dai, Chia-Yen; Lee, Jang-Ming; Huang, Jee-Fu; Koong, Albert C.; Lin, Jou-Wei; Chuang, Eric Y.; Liang, Cheng-Chao; Yang, Sheng-Shun; Lin, Chih-Lin; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung; Hsu, Feng-Ming;Cheng, Jason Chia-Hsien;Chang, Yih-Leong;Lee, Jang-Ming;Koong, Albert C.;Chuang, Eric Y.; Hsu, F.-M. and Cheng, J.C.-H. and Chang, Y.-L. and Lee, J.-M. and Koong, A.C. and Chuang, E.Y.; 張逸良;成佳憲;李章銘;許峰銘; 成佳憲 |
显示项目 11-20 / 491 (共50页)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目
|
